NYU Data Catalog

NYU Dataset

Alternate Title(s): TASSH Study
Authors: Gbenga Ogedegbe

Jacob Plange-Rhule

Joyce Gyamfi

William Chaplin

9 more author(s)...
Description: The dataset includes a total of 757 patients with uncontrolled hypertension who were enrolled into the Task Shifting and Blood Pressure Control in Ghana (TASSH) study through 32 community health centers in Ghana. TASSH was a randomized controlled trial that compared the outcomes of 2 interventions to reduce systolic blood pressure (SBP): standard of care treatment available through public health insurance...
Subject: Chronic Disease

Health Care System
Access Rights: Free to All

NYU Dataset

Alternate Title(s): Evaluation of Metronomic Chemotherapy Response Using dMRI and DCE MRI
Authors: Mehran Baboli

Kerryanne V. Winters

Melanie Freed

Jin Zhang

1 more author(s)...
Description: The dataset contains data collected from twelve Balb/c mice with metastatic breast cancer (4T1 mammary tumors). Six mice were in the control group and six mice were treated with 5-Fluorouracil (5FU) for metronomic chemotherapy for two weeks. Diffusion MRI (dMRI) and Dynamic Contrast-enhanced MRI (DCE-MRI) images were collected at baseline and post-treatment. Immunohistochemically (IHC) stains and measurements...
Subject: Cancer
Access Rights: Free to All

NYU Dataset

Authors: Douglas K. Marks

Nibash Budhathoki

John Kucharczyk

Faisal Fa'ak

20 more author(s)...
Description: Data was abstracted from NYU Langone Health electronic health records, the Perlmutter Cancer Center Data Hub, and the NYU Langone Health SARS-CoV-2 Data Mart for all patients treated for breast cancer at Perlmutter Cancer Center either through telemedicine or in-person between February 1, 2020 and May 1, 2020 to determine the incidence of SARS-CoV-2 infection associated with treatment with cytotoxic...
Timeframe: 2020
Access Rights: Application Required

Author Approval Required

Authors: Graham Jackson
Description: Randomised Comparisons, in Myeloma Patients of All Ages, of Thalidomide, Lenalidomide, Carfilzomib and Bortezomib Induction Combinations, and of Lenalidomide and Combination Lenalidomide Vorinostat as Maintenance (Myeloma XI) was a randomized controlled trial which recruited 4420 patients in the United Kingdom who were newly diagnosed with symptomatic or non-secretory multiple myeloma to study the...
Subject: Cancer

Genomics
Access Rights: Author Approval Required
Local Expert: Gareth J. Morgan

Alternate Title(s): CoMMpass
Description: The Relating Clinical Outcomes in MM to Personal Assessment of Genetic Profile (CoMMpass) trial is a longitudinal observational study sponsored by the Multiple Myeloma Research Foundation (MMRF) which follows adult patients with newly diagnosed and symptomatic myeloma over a 10 year period. The study began in 2011 and has enrolled 1154 participants across the United States, Canada, and Spain. Study...
Subject: Cancer

Genomics
Access Rights: Free to All

Application Required
Local Expert: Gareth J. Morgan

Authors: Samuel A. Danziger

Mark McConnell

Jake Gockley

Mary H. Young

29 more author(s)...
Description: This dataset contains data on the tumor microenvironment from the whole bone marrow of 436 patients who were diagnosed with multiple myeloma and enrolled in the interventional Total Therapy trial series conducted by the University of Arkansas for Medical Sciences. 266 male and 170 female patients were enrolled between February 25, 2004 and January 11, 2014 and completed 25 to 5,241 days of follow-up...
Subject: Cancer

Chronic Disease

Genomics
Access Rights: Free to All
Local Expert: Gareth J. Morgan